Literature DB >> 14680423

Unintended outcomes of medicaid drug cost-containment policies on the chronically mentally ill.

Stephen Soumerai1.   

Abstract

Cost-containment policies frequently focus on reducing drug expenditures, although prescription drug costs are a relatively small proportion of total health care expenditures. Data show that very few drug cost-containment policies can selectively reduce unneeded care while maintaining essential care. In the early 1980s, the New Hampshire Medicaid program introduced a drug-payment limit (a "cap") that set the number of reimbursable medications a patient could receive per month at 3. Analyses reviewed in this article indicate that New Hampshire's drug cap, while in effect, reduced the use of prescription drugs among the elderly and the mentally ill but increased hospital and nursing home admissions, partial hospitalizations, distribution of psychoactive medications by community mental health centers, and use of emergency mental health services. Vulnerable populations are most likely to experience adverse effects from hastily-applied drug cost-containment policies, and resulting compensatory measures may create more expenses than the policy removes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14680423

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

1.  Factors Associated with Geographic Variation in Psychiatric Prescription Drug Expenditures Among Medicaid Beneficiaries.

Authors:  Julia Zur; Leighton Ku
Journal:  J Behav Health Serv Res       Date:  2016-07       Impact factor: 1.505

2.  Evaluating diabetes health policies using natural experiments: the natural experiments for translation in diabetes study.

Authors:  Ronald T Ackermann; O Kenrik Duru; Jeanine B Albu; Julie A Schmittdiel; Stephen B Soumerai; James F Wharam; Mohammed K Ali; Carol M Mangione; Edward W Gregg
Journal:  Am J Prev Med       Date:  2015-06       Impact factor: 5.043

3.  Strategies for coping in a complex world: adherence behavior among older adults with chronic illness.

Authors:  Rachel A Elliott; Dennis Ross-Degnan; Alyce S Adams; Dana Gelb Safran; Stephen B Soumerai
Journal:  J Gen Intern Med       Date:  2007-04-05       Impact factor: 5.128

4.  Association Between Medicaid Prescription Drug Limits and Access to Medications and Health Care Use Among Young Adults With Disabilities.

Authors:  Caroline K Geiger; Jessica L Cohen; Benjamin D Sommers
Journal:  JAMA Health Forum       Date:  2021-06-17

5.  Polypharmacy with antipsychotic drugs in patients with schizophrenia: trends in multiple health care systems.

Authors:  FangFang Sun; Eileen M Stock; Laurel A Copeland; John E Zeber; Brian K Ahmedani; Sandra B Morissette
Journal:  Am J Health Syst Pharm       Date:  2014-05-01       Impact factor: 2.637

6.  A best-worst scaling experiment to identify patient-centered claims-based outcomes for evaluation of pediatric antipsychotic monitoring programs.

Authors:  Thomas I Mackie; Katherine M Kovacs; Cassandra Simmel; Stephen Crystal; Sheree Neese-Todd; Ayse Akincigil
Journal:  Health Serv Res       Date:  2020-12-28       Impact factor: 3.402

7.  Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand.

Authors:  Tuanthon Boonlue; Suphat Subongkot; Piyameth Dilokthornsakul; Ronnachai Kongsakon; Oraluck Pattanaprateep; Orabhorn Suanchang; Nathorn Chaiyakunapruk
Journal:  Clinicoecon Outcomes Res       Date:  2016-04-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.